Skip to Content

Orchid Pharma Ltd 524372

Morningstar Rating
INR 1,142.85 +7.15 (0.63%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

524372 is trading at a 346% premium.
Price
INR 1,144.63
Fair Value
INR 8,221.44
Uncertainty
High
1-Star Price
INR 1,476.86
5-Star Price
INR 773.33
Economic Moat
Rkrvw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 524372 is a good fit for your portfolio.

Trading Information

Previous Close Price
INR 1,135.70
Day Range
INR 1,125.351,147.00
52-Week Range
INR 432.351,358.80
Bid/Ask
INR 0.00 / INR 0.00
Market Cap
INR 57.96 Bil
Volume/Avg
4,734 / 21,797

Key Statistics

Price/Earnings (Normalized)
56.62
Price/Sales
6.74
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
958

Comparables

Valuation

Metric
524372
524348
543434
Price/Earnings (Normalized)
56.6229.9527.81
Price/Book Value
4.963.974.06
Price/Sales
6.742.015.81
Price/Cash Flow
47.0422.6625.50
Price/Earnings
524372
524348
543434

Financial Strength

Metric
524372
524348
543434
Quick Ratio
1.800.912.49
Current Ratio
3.041.665.17
Interest Coverage
6.628.0379.53
Quick Ratio
524372
524348
543434

Profitability

Metric
524372
524348
543434
Return on Assets (Normalized)
6.88%7.10%13.83%
Return on Equity (Normalized)
10.14%13.89%15.76%
Return on Invested Capital (Normalized)
9.17%10.74%15.72%
Return on Assets
524372
524348
543434
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
VnkbcztfVxgvp$79.8 Bil
Merck KGaA ADR
MKKGY
PkxwnrzpCmwbf$71.7 Bil
Haleon PLC ADR
HLN
YcnxypytCqdj$37.9 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
NxdwbgvNldxp$13.0 Bil
Viatris Inc
VTRS
JrmnwhpNkym$12.3 Bil
Catalent Inc
CTLT
GcyczbwwlYzvqmsm$10.3 Bil
Perrigo Co PLC
PRGO
GvjmlmnjFvqv$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
VkhmfjymnXzwhsv$3.4 Bil
Curaleaf Holdings Inc
CURLF
VbkxrpkHttys$2.8 Bil
Green Thumb Industries Inc
GTBIF
GxpbkxnpFmkfs$2.7 Bil

Sponsor Center